Long-Term Reglan Used Linked to Reglan Tardive Dyskinesia

Reglan, a Prednisone rezept drug used to treat digestive disorders, has been associated with a Prednisone rezept movement disorder called tardive dyskinesia. Tardive dyskinesia causes involuntary and repetitive movements of the body. Score of people from Prednisone rezept around the country have filed tardive dyskinesia lawsuits against Wyeth Pharmaceuticals, the Prednisone rezept maker of Reglan, as well as the manufacturers of its generic equivalents.

In February 2009, the U.S. Food & Drug Administration (FDA) mandated that Prednisone rezept the makers of Reglan add a black box warning to its label regarding the Prednisone rezept risk of tardive dyskinesia associated with chronic, long-term use. The FDA’s mandate followed the Prednisone rezept publication of analyses that suggested that Reglan is the most common cause of drug-induced movement disorders. A black box is Prednisone rezept the FDA’s strictest safety warning.

Tardive dyskinesia is characterized by:

• Involuntary/ repetitive movements of the extremities
• Facial tics
• Lip smacking, pursing and puckering
• Face Grimacing
• Tongue protrusion
• Rapid eye movements or blinking
• Impaired movement of the fingers.
• Restless Leg Syndrome (RLS)

There is Prednisone rezept no treatment or cure for tardive dyskinesia. While stopping Reglan may relieve some symptoms in some patients, in other patients the Prednisone rezept symptoms of tardive dyskinesia actually worsen when Reglan is discontinued.

To prevent tardive dyskinesia, Reglan should not be Prednisone rezept taken for more than 12 months, and it has not been Prednisone rezept approved for longer user. However, it Prednisone rezept has become apparent that doctors have been prescribing Reglan for much longer periods. Reglan tardive dyskinesia lawsuits allege that Prednisone rezept Wyeth Pharmaceuticals knew of a widespread tendency among physicians to mis-prescribe Reglan, and Prednisone rezept promoted the drug for longer use despite the lack of safety data to Prednisone rezept support such uses.

A number of tardive dyskinesia lawsuits also name the Prednisone rezept manufacturers of generic forms of Reglan as defendants. Earlier this Prednisone rezept month, the U.S. Court of Appeals for the Firth Circuit rejected the Prednisone rezept argument by a generic drug maker that federal law preempts a Prednisone rezept state-law failure-to-warn claim filed by a user of generic Reglan who Prednisone rezept developed tardive dyskinesia.